Real‐world utility of HCV core antigen as an alternative to HCV RNA testing: Implications for viral load and genotype
Open Access
- 1 June 2020
- journal article
- research article
- Published by Wiley in Journal of Viral Hepatitis
- Vol. 27 (10) , 996-1002
Abstract
Following positive serology, the gold standard confirmatory test of hepatitis C virus (HCV) infection is detection of HCV RNA by PCR. We assessed the utility of HCV core antigen testing to identify active infection among those positive for anti‐HCV antibodies, when introduced to routine testing. We identified serum samples that were tested at a single laboratory in Scotland from June 2011to December 2017. Serum samples testing positive for HCV antibodies (HCV Ab positive) followed by reflex HCV core antigen (Ag) testing during the study period were identified. Those patients for whom a PCR test was requested on the baseline sample were also identified. For this group, the sensitivity and specificity of HCV Ag as a diagnostic tool were assessed using HCV PCR as gold standard. In our cohort of 744 patients, we demonstrated a sensitivity of 82.1% (95% CI 77.1%‐86.2%) and a specificity of 99.8% (95% CI 98.6%‐100%). Genotype 3 was associated with increased odds of a false‐negative result (OR = 3.59, 95% CI: 1.32‐9.71), and reduced odds of a false negative were associated with older age (odds ratio (OR)=0.92, 95% CI: 0.88‐0.97 per year) and viral load (OR = 0.10, 95% CI: 0.05‐0.21 per log10 IU/ml). While the implementation of HCV core antigen testing for diagnosis could lead to significant cost savings in national screening programmes, our data suggest that a significant proportion of HCV‐infected individuals may be missed. These findings have implications for HCV diagnosis and determination of viral clearance after treatment, particularly in low‐ and middle‐income regions, where genotype 3 is prevalent.Keywords
This publication has 21 references indexed in Scilit:
- Quantification of Core Antigen Monitors Efficacy of Direct-acting Antiviral Agents in Patients With Chronic Hepatitis C Virus InfectionClinical Gastroenterology and Hepatology, 2016
- Hepatitis C reinfection following treatment induced viral clearance among people who have injected drugsDrug and Alcohol Dependence, 2016
- Hepatitis C Virus Core Mutations Associated with False-Negative Serological Results for Genotype 3a Core AntigenJournal of Clinical Microbiology, 2015
- Clinical utility of hepatitis C virus core antigen quantification in patients with chronic hepatitis CJournal of Clinical Virology, 2014
- Rise in testing and diagnosis associated with Scotland's Action Plan on Hepatitis C and introduction of dried blood spot testingJournal of Epidemiology and Community Health, 2014
- HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypesBMC Infectious Diseases, 2014
- Detection limit of architect hepatitis C core antigen assay in correlation with HCV RNA, and renewed confirmation algorithm for reactive anti-HCV samplesJournal of Clinical Virology, 2013
- Correlation of Viral Loads with HCV Genotypes: Higher Levels of Virus Were Revealed among Blood Donors Infected with 6a StrainsPLOS ONE, 2012
- Japanese Reference Panel of Blood Specimens for Evaluation of Hepatitis C Virus RNA and Core Antigen Quantitative AssaysJournal of Clinical Microbiology, 2012
- Multiple imputation using chained equations: Issues and guidance for practiceStatistics in Medicine, 2010